Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Maher

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Cancer Research|May 14, 2009
EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastomaBipasha Mukherjee, Brian McEllin, Cristel V Camacho, et al.
Cancer Research|November 9, 2006
A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastomaFenghua Liu, Peter J Park, Weil Lai, et al.
Breast (Edinburgh, Scotland)|June 25, 2021
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer - A retrospective cohort studyMatthew G Davey, Eoin Kerin, C O'Flaherty, et al.
Advances in Radiation Oncology|July 4, 2025
Comparative Outcomes of Standard Radiation Therapy and 5-Fraction Adaptive Stereotactic Radiation Therapy in Newly Diagnosed Glioblastoma: A Propensity Score-Matched AnalysisMichael Dohopolski, Luiza Giuliani Schmitt, Jill de Vis, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2026
Adaptive MRI-Guided Reirradiation for High-Risk Recurrent Grade 4 Gliomas: Early Clinical Outcomes and Volumetric ResponseLuiza Giuliani Schmitt, Michael Dohopolski, Jill de Vis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Ivosidenib in Isocitrate Dehydrogenase 1<i>-</i>Mutated Advanced GliomaIngo K Mellinghoff, Benjamin M Ellingson, Mehdi Touat, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2006
Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitorsHongbin Ji, Xiaojun Zhao, Yuki Yuza, et al.
Neuro-Oncology|December 23, 2015
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant gliomaMacarena I de la Fuente, Robert J Young, Jennifer Rubel, et al.
The Lancet. Oncology|November 1, 2025
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trialTimothy F Cloughesy, Martin J van den Bent, Mehdi Touat, et al.
International Journal of Clinical and Health Psychology : IJCHP|August 25, 2021
An international study on psychological coping during COVID-19: Towards a meaning-centered coping styleNikolett Eisenbeck, David F Carreno, Paul T P Wong, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancer Research|May 14, 2009
EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastomaBipasha Mukherjee, Brian McEllin, Cristel V Camacho, et al.
Cancer Research|November 9, 2006
A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastomaFenghua Liu, Peter J Park, Weil Lai, et al.
Breast (Edinburgh, Scotland)|June 25, 2021
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer - A retrospective cohort studyMatthew G Davey, Eoin Kerin, C O'Flaherty, et al.
Advances in Radiation Oncology|July 4, 2025
Comparative Outcomes of Standard Radiation Therapy and 5-Fraction Adaptive Stereotactic Radiation Therapy in Newly Diagnosed Glioblastoma: A Propensity Score-Matched AnalysisMichael Dohopolski, Luiza Giuliani Schmitt, Jill de Vis, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2026
Adaptive MRI-Guided Reirradiation for High-Risk Recurrent Grade 4 Gliomas: Early Clinical Outcomes and Volumetric ResponseLuiza Giuliani Schmitt, Michael Dohopolski, Jill de Vis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Ivosidenib in Isocitrate Dehydrogenase 1<i>-</i>Mutated Advanced GliomaIngo K Mellinghoff, Benjamin M Ellingson, Mehdi Touat, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2006
Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitorsHongbin Ji, Xiaojun Zhao, Yuki Yuza, et al.
Neuro-Oncology|December 23, 2015
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant gliomaMacarena I de la Fuente, Robert J Young, Jennifer Rubel, et al.
The Lancet. Oncology|November 1, 2025
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trialTimothy F Cloughesy, Martin J van den Bent, Mehdi Touat, et al.
International Journal of Clinical and Health Psychology : IJCHP|August 25, 2021
An international study on psychological coping during COVID-19: Towards a meaning-centered coping styleNikolett Eisenbeck, David F Carreno, Paul T P Wong, et al.
Pageof 4